The Drug Enforcement Administration recently decided to add cannabidiol to its Schedule I substance list. The change directly affects both hemp and cannabis-derived CBD oil, a substance that is non-psychoactive and has more medical benefits than we can name.
The DEA’s move raises a lot of questions, including these: What, exactly, is CBD? And how does it differ from THC?
